Home / Tag Archives: teva pharmaceutical industries

Tag Archives: teva pharmaceutical industries

Teva Receives FDA Approval For First Waterless Nasal Aerosol for Allergic Rhinitis In Young Children טבע הודיעה על קבלת אישור לפורמולציה במינון נמוך יותר של תרסיס לאף לילדים

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) has announced that the U.S. Food and Drug Administration (FDA) approved QNASL® (beclomethasone dipropionate) 40 mcg for treatment of seasonal and year-round nasal symptoms associated with allergic rhinitis (AR) in children 4-11 years of age. An ...

Read More »

Teva Pharmaceutical Industries (NYSE:TEVA; TASE:TEVA) Recalls Parkinson’s Disease Medication טבע תעשיות פרמצבטיות מבצעת ריקול בתרופה למחלת פרקינסון

Teva Pharmaceutical Industries Ltd. is issuing a Class II recall of one lot (3,881 bottles) of carbidopa/levodopa 25 mg/100 mg, a generic drug used to treat Parkinson’s disease, due to the potential for “superpotent” tablets. The lot in question was manufactured ...

Read More »